Trade BioNTech ^BNTX

HC Wainwright Reiterates Buy Rating for BioNTech (NASDAQ:BNTX)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders | Morningstar

Q4 Earnings Forecast for BioNTech Issued By HC Wainwright

Big Pharma CEOs rake in millions in compensation while patients struggle with sky-high drug prices - NaturalNews.com

HC Wainwright Has Negative Outlook for BioNTech Q4 Earnings

ADC cancer drugs: Pfizer, AstraZeneca, Merck bet on chemo replacement

BioNTech (NASDAQ:BNTX) Price Target Cut to $138.00 by Analysts at HC Wainwright

Covington, Hengeler, Skadden and Latham Advise on BioNTech's $1.25B Takeover of German Rival

BioNTech SE (NASDAQ:BNTX) Given Average Recommendation of "Moderate Buy" by Brokerages

BioNTech's CureVac Deal Signals Deep Pivot Toward mRNA Cancer Therapies

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN) | Morningstar

CureVac downgraded to Hold from Buy at Jefferies | Markets Insider

Health Care Climbs Amid Deal Activity - Health Care Roundup | Morningstar

Dow Jones Top Company Headlines at 1 PM ET: Micron Technology to Invest $200 Billion in U.S. Semiconductor Manufacturing | BioNTech ... | Morningstar

Citi's Metzger on Asia Pacific's M&A, IPO Rush: Bloomberg Deals

Dow Jones Top Company Headlines at 11 AM ET: Micron Technology to Invest $200 Billion in U.S. Semiconductor Manufacturing | BioNTech ... | Morningstar

International business briefs: Syrians to go full crypto

Dow Jones Top Company Headlines at 9 AM ET: BioNTech to Buy CureVac in Stock Deal Valued Around $1.25 Billion | Tesco ... | Morningstar

BioNtech to buy CureVac in $1.25 billion share deal to boost cancer focus | Markets News - Business Standard

BioNTech to acquire CureVac in $1.25 billion all-stock deal

BioNTech To Acquire CureVac In All-stock Deal With Aggregate Equity Value Of Approx. $1.25 Bln

Biontech's $1.25B Curevac buyout removes mRNA lawsuit uncertainty | BioWorld

Wall Street Zen Upgrades BioNTech (NASDAQ:BNTX) to Hold

Equities Analysts Offer Predictions for BioNTech Q1 Earnings

TB Alternative Assets Ltd. Acquires Shares of 38,996 BioNTech SE (NASDAQ:BNTX)

BioNTech (NASDAQ:BNTX) Price Target Raised to $145.00

BioNTech (NASDAQ:BNTX) Upgraded at Wall Street Zen

HC Wainwright Forecasts Strong Price Appreciation for BioNTech (NASDAQ:BNTX) Stock

Preliminary Data from Two Clinical Trials with ADC Candidates were Presented Orally at the 2025 ASCO Annual Meeting | The Manila Times

AstraZeneca, BioNTech and CIC back Sortera Bio's £7.5m pre-seed round

Truist Lifts BioNTech (BNTX) Price Target After New Partnership

Healthy Returns: AstraZeneca, Pfizer, Gilead release cancer drug data

Bristol-Myers Squibb (NYSE:BMY) Collaborates With BioNTech For Antibody Development In Cancer Treatment

BioNTech (NASDAQ:BNTX) Sees Large Volume Increase - Here's Why

BioNTech (NASDAQ:BNTX) Shares Gap Up - Time to Buy?

BioNTech (NASDAQ:BNTX) Given Buy Rating at Truist Financial

Dow Jones Top Company Headlines at 3 AM ET: TSMC Sees Limited Tariff Impact on AI Strength | How ... | Morningstar

Why BioNTech SE (BNTX) Skyrocketed On Monday

Dow Jones Top Company Headlines at 1 AM ET: How Moderna Went From Pandemic Hero to Vaccine Victim | Paramount ... | Morningstar

Dow Jones Top Company Headlines at 11 PM ET: How Moderna Went From Pandemic Hero to Vaccine Victim | Paramount ... | Morningstar

Bristol-Myers Squibb Company and BioNTech SE Partner to Advance Next-Gen Cancer Therapies

Dow Jones Top Company Headlines at 7 PM ET: Walt Disney Co. to Lay Off Hundreds | Jamie ... | Morningstar

These 10 Stocks Blew Past Expectations

Dow Jones Top Company Headlines at 5 PM ET: Walt Disney Co. to Lay Off Hundreds | Jamie ... | Morningstar

Bristol Myers' cancer deal is promising, but doesn't change our stance on stock yet

Bristol Myers agrees up to $11.1 billion deal with BioNTech to shake up cancer immunotherapy

Bristol-Myers and BioNTech: Oncology Collaboration Further Solidifies BNT327's Potential | Morningstar

Bristol-Myers (BMY) Licenses BioNTech's Immunotherapy in $11 billion Deal

Dow Jones Top Company Headlines at 9 AM ET: Campbell's Posts Higher Sales as Consumers Return to Cooking at Home | BioNTech ... | Morningstar

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race | Morningstar

Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal (2)

Bristol Myers to help develop cancer drug in BioNTech partnership

BioNTech Sets Cancer-Drug Deal With Bristol Myers Potentially Worth More Than $11 Billion | Morningstar

Bristol Myers to Pay $1.5B for BioNTech Cancer Drug Deal | Newsmax.com

BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types | The Manila Times

Bristol-Myers to Pay BioNTech Up to $11.1 Billion in Cancer Deal

BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types | Morningstar

BioNTech, Bristol Myers Ink Strategic Partnership To Co-Develop BNT327 For Several Solid Tumor Type

Biontech trades half of bispecific BNT-327 to BMS for potential $11B+ | BioWorld

Wall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to Sell

BioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting | The Manila Times

MAINZ, Germany, May 27, 2025 -- BioNTech SE (Nasdaq: BNTX, "

AI-Driven mRNA Therapeutics Market Development Accelerated by AI Integration in Drug Design Delivery and Scalable Manufacturing

Cambridge R&D Centre being created by BioNTech in £1bn UK spree

Amazon Stock Prediction: Where Will AMZN Stock Go in the Next 5 Years

U.S. Stock Movers Today: ULY, NNNN, QS, GCTK, RITR

Trending CFD trading platforms 2025: MT4, MT5, Pepperstone, eToro and more

Commodity market today: gold retreats to $3327, silver holds near $36

Walmart Stock Outlook: How Will the New Retail Strategy Affect WMT Stock?

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Moderna share price jumps as Oppenheimer upgrades stock

Pfizer shares sink on lower COVID revenue prospects

5 Stocks to Fall in Love with this Valentines Day

Stocks make further gains as oil bounce carries on

Stock Mover Today: Why BAC Stock Is Trending Now?

MSTR Stock News: MSTR Shares Rise 1.9% Amid Mixed Options Market Sentiment

Stock indexes today: Dow Jumps 500 Points, S&P 500 Rises on Trump Ceasefire

Value of bitcoin today: BTC/USD over 106K as Middle East tensions eased

Market movers today: Carnival, Tesla, Mastercard, SOFI

Morning Note: Ceasefire Boosts Markets; Dovish Fed & RBA Rate Cut Bets Emerge

Morning Note: Powell on Tariffs; Oil Rebounds; Aussie Inflation Cools

IBO stock up 200% today: what’s going on with Impact Biomedical